marketcaparena
Search

    HRTX

    HERON THERAPEUTICS, INC. /DE/

    Company overview

    Market capitalization
    $55.40M
    Employees
    128
    Latest publication
    2026-09-29
    About HERON THERAPEUTICS, INC. /DE/

    Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. Heron Therapeutics, Inc. was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. The company was founded in 1983 and is headquartered in Cary, North Carolina.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue34,711,000USD40,588,000USD38,213,000USD37,200,000USD38,903,000USD40,781,000USD32,810,000USD36,024,000USD
    Cost Of Revenue10,638,000USD7,649,000USD15,384,000USD9,857,000USD8,457,000USD10,228,000USD9,458,000USD10,518,000USD
    Gross Profit24,073,000USD32,939,000USD22,829,000USD27,343,000USD30,446,000USD30,553,000USD23,352,000USD25,506,000USD
    Research Development2,385,000USD3,746,000USD3,470,000USD2,934,000USD2,279,000USD3,178,000USD4,465,000USD4,432,000USD
    Selling General Administrative12,145,000USD13,452,000USD13,980,000USD14,471,000USD12,702,000USD12,145,000USD12,373,000USD13,905,000USD
    Selling And Marketing Expenses14,308,000USD12,233,000USD—11,575,000USD12,311,000USD11,057,000USD10,972,000USD13,614,000USD
    Total Operating Expenses28,838,000USD32,901,000USD26,922,000USD28,980,000USD27,292,000USD26,380,000USD27,810,000USD31,951,000USD
    Operating Income-4,765,000USD38,000USD-4,093,000USD-1,637,000USD3,154,000USD4,173,000USD-4,458,000USD-6,445,000USD
    Income Before Tax-8,111,000USD-2,954,000USD-17,495,000USD-2,381,000USD2,635,000USD3,663,000USD-4,848,000USD-9,235,000USD
    Net Income-8,111,000USD-2,954,000USD-17,495,000USD-2,381,000USD2,635,000USD3,663,000USD-4,848,000USD-9,235,000USD
    Net Income From Continuing Ops-8,111,000USD-2,954,000USD-17,495,000USD-2,381,000USD2,635,000USD3,663,000USD-4,848,000USD-9,235,000USD
    Ebitda-4,765,000USD-792,000USD-13,980,000USD-1,026,000USD3,705,000USD8,734,000USD-3,877,000USD-5,804,000USD
    Reconciled Depreciation529,000USD537,000USD615,000USD611,000USD551,000USD581,000USD581,000USD641,000USD
    Total Other Income Expense Net-3,346,000USD-2,992,000USD-13,402,000USD-744,000USD-519,000USD-510,000USD-390,000USD-2,790,000USD
    Unclassified Operating Expenses—3,470,000USD9,472,000USD—————
    Interest Expense—1,000,000USD2,900,000USD500,000USD500,000USD4,432,000USD500,000USD400,000USD
    Ebit—-1,954,000USD-14,595,000USD-1,637,000USD3,154,000USD8,153,000USD-4,458,000USD-6,445,000USD
    Depreciation And Amortization—1,162,000USD615,000USD611,000USD551,000USD581,000USD581,000USD641,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue154,904,000USD144,285,000USD127,044,000USD107,672,000USD86,346,000USD88,638,000USD145,968,000USD77,474,000USD
    Cost Of Revenue41,347,000USD38,648,000USD65,105,000USD54,874,000USD46,021,000USD36,189,000USD61,619,000USD27,512,000USD
    Gross Profit113,557,000USD105,637,000USD61,939,000USD52,798,000USD40,325,000USD52,449,000USD84,349,000USD49,962,000USD
    Research Development12,429,000USD16,683,000USD39,133,000USD107,506,000USD130,821,000USD174,533,000USD167,382,000USD140,032,000USD
    Selling General Administrative54,605,000USD53,397,000USD58,478,000USD37,437,000USD40,153,000USD42,226,000USD37,897,000USD29,263,000USD
    Selling And Marketing Expenses49,061,000USD47,085,000USD61,343,000USD82,513,000USD87,179,000USD63,853,000USD89,764,000USD64,604,000USD
    Total Operating Expenses116,095,000USD117,165,000USD172,554,000USD227,456,000USD258,153,000USD280,612,000USD295,043,000USD233,899,000USD
    Operating Income-2,538,000USD-11,528,000USD-110,615,000USD-174,658,000USD-217,828,000USD-228,163,000USD-210,694,000USD-183,937,000USD
    Interest Income1,948,000USD3,550,000USD3,364,000USD1,638,000USD433,000USD3,633,000USD7,259,000USD5,965,000USD
    Interest Expense9,605,000USD6,032,000USD3,868,000USD2,474,000USD2,410,000USD1,901,000USD1,472,000USD2,672,000USD
    Net Interest Income-7,657,000USD-2,482,000USD-504,000USD-836,000USD-1,977,000USD1,732,000USD5,787,000USD3,293,000USD
    Income Before Tax-20,195,000USD-13,580,000USD-110,559,000USD-182,024,000USD-220,683,000USD-227,278,000USD-204,749,000USD-178,840,000USD
    Net Income-20,195,000USD-13,580,000USD-110,559,000USD-134,516,000USD-217,662,000USD-224,431,000USD-204,749,000USD-178,840,000USD
    Net Income From Continuing Ops-20,195,000USD-13,580,000USD-119,704,000USD-182,024,000USD-220,683,000USD-227,278,000USD-204,749,000USD-178,840,000USD
    Ebit-20,195,000USD-7,548,000USD-106,691,000USD-174,658,000USD-217,828,000USD-228,163,000USD-203,277,000USD-183,937,000USD
    Ebitda-17,881,000USD-5,056,000USD-103,792,000USD-171,769,000USD-214,807,000USD-225,316,000USD-201,233,000USD-182,424,000USD
    Depreciation And Amortization2,314,000USD2,492,000USD2,899,000USD2,889,000USD3,021,000USD2,847,000USD2,044,000USD1,513,000USD
    Reconciled Depreciation2,314,000USD2,492,000USD2,975,000USD2,889,000USD3,021,000USD2,847,000USD2,044,000USD1,513,000USD
    Total Other Income Expense Net-17,657,000USD-2,052,000USD56,000USD-7,366,000USD-2,855,000USD885,000USD5,945,000USD5,097,000USD
    Unclassified Operating Expenses——13,600,000USD—————
    Income Tax Expense——2,731,105USD-47,508,000USD-3,021,000USD-2,847,000USD1,872,000USD7,769,000USD
    Net Income Applicable To Common Shares———-182,024,000USD-220,683,000USD-227,278,000USD-204,749,000USD-178,840,000USD
    Non Operating Income Net Other————-445,000USD2,786,000USD7,417,000USD7,769,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets246,216,000USD255,877,000USD248,950,000USD232,090,000USD235,752,000USD233,147,000USD220,777,000USD218,136,000USD
    Other Current Assets7,968,000USD9,102,000USD22,841,000USD17,394,000USD26,494,000USD17,690,000USD11,308,000USD7,249,000USD
    Total Liab237,079,000USD241,544,000USD234,065,000USD259,348,000USD264,205,000USD266,798,000USD260,782,000USD256,076,000USD
    Total Stockholder Equity9,137,000USD14,333,000USD14,885,000USD-27,258,000USD-28,453,000USD-33,651,000USD-40,005,000USD-37,940,000USD
    Other Current Liab81,546,000USD87,104,000USD76,911,000USD69,821,000USD73,934,000USD76,711,000USD72,107,000USD66,897,000USD
    Common Stock1,886,000USD1,883,000USD1,833,000USD1,533,000USD1,524,000USD1,521,000USD1,517,000USD1,516,000USD
    Capital Stock2,936,000USD2,933,000USD9,695,000USD1,533,000USD1,524,000USD1,521,000USD1,517,000USD1,516,000USD
    Retained Earnings-1,947,900,000USD-1,939,789,000USD-1,936,835,000USD-1,919,340,000USD-1,916,959,000USD-1,919,594,000USD-1,923,257,000USD-1,918,409,000USD
    Cash26,117,000USD28,647,000USD43,068,000USD16,516,000USD19,269,000USD25,802,000USD25,741,000USD18,386,000USD
    Cash And Short Term Investments44,784,000USD46,631,000USD55,487,000USD40,633,000USD50,679,000USD59,283,000USD70,890,000USD67,347,000USD
    Total Current Assets228,984,000USD238,066,000USD229,400,000USD210,923,000USD212,841,000USD209,014,000USD195,187,000USD191,168,000USD
    Total Current Liabilities90,516,000USD96,098,000USD89,708,000USD258,601,000USD88,557,000USD91,457,000USD85,544,000USD80,317,000USD
    Net Debt115,517,000USD111,991,000USD97,375,000USD160,227,000USD157,987,000USD151,961,000USD152,505,000USD160,326,000USD
    Short Long Term Debt Total141,634,000USD140,638,000USD140,443,000USD176,743,000USD177,256,000USD177,763,000USD178,246,000USD178,712,000USD
    Long Term Debt141,634,000USD140,638,000USD139,663,000USD—174,966,000USD174,726,000USD174,475,000USD174,229,000USD
    Short Term Investments18,667,000USD17,984,000USD12,419,000USD24,117,000USD31,410,000USD33,481,000USD45,149,000USD48,961,000USD
    Net Receivables83,693,000USD89,587,000USD81,047,000USD79,931,000USD78,736,000USD78,881,000USD67,039,000USD73,708,000USD
    Inventory92,539,000USD92,746,000USD70,025,000USD72,965,000USD56,932,000USD53,160,000USD45,950,000USD42,864,000USD
    Accounts Payable8,970,000USD8,994,000USD12,017,000USD12,037,000USD12,333,000USD11,709,000USD10,188,000USD10,226,000USD
    Property Plant Equipment Net12,025,000USD12,403,000USD13,668,000USD15,084,000USD16,628,000USD17,650,000USD18,883,000USD20,038,000USD
    Accumulated Other Comprehensive Income-6,000USD4,000USD—-1,000USD1,000USD13,000USD40,000USD-8,000USD
    Common Stock Shares Outstanding189,646,000shares166,707,000shares170,348,000shares154,020,000shares153,490,000shares153,151,000shares152,830,000shares152,305,000shares
    Non Current Assets Total17,232,000USD17,811,000USD19,550,000USD21,167,000USD22,911,000USD24,133,000USD25,590,000USD26,968,000USD
    Non Current Liabilities Total146,563,000USD145,446,000USD144,357,000USD747,000USD175,648,000USD175,341,000USD175,238,000USD175,759,000USD
    Non Current Liabilities Other4,929,000USD4,808,000USD4,694,000USD747,000USD682,000USD615,000USD241,000USD241,000USD
    Non Currrent Assets Other5,207,000USD5,408,000USD5,882,000USD6,083,000USD6,283,000USD6,483,000USD6,707,000USD6,930,000USD
    Net Working Capital138,468,000USD141,968,000USD139,692,000USD-47,678,000USD124,284,000USD117,557,000USD109,643,000USD110,851,000USD
    Unclassified Equity1,952,221,000USD1,949,302,000USD1,940,192,000USD1,889,017,000USD1,885,457,000USD1,882,888,000USD1,880,178,000USD1,877,445,000USD
    Property Plant Equipment Gross—25,283,000USD13,668,000USD15,084,000USD16,628,000USD35,497,000USD18,883,000USD20,038,000USD
    Short Term Debt——780,000USD176,743,000USD2,290,000USD3,037,000USD3,249,000USD3,194,000USD
    Short Long Term Debt———175,204,000USD————
    Unclassified Current Liabilities———-175,204,000USD————
    Other Assets———————1USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets255,877,000USD233,147,000USD222,506,000USD250,951,000USD305,706,000USD353,556,000USD512,782,000USD462,179,000USD
    Other Current Assets9,102,000USD17,690,000USD6,118,000USD13,961,000USD12,962,000USD21,950,000USD23,245,000USD22,386,000USD
    Total Liab241,544,000USD266,798,000USD256,479,000USD237,379,000USD228,136,000USD117,064,000USD108,947,000USD92,019,000USD
    Total Stockholder Equity14,333,000USD-33,651,000USD-33,973,000USD13,572,000USD77,570,000USD236,492,000USD403,835,000USD370,160,000USD
    Other Current Liab87,104,000USD76,711,000USD72,811,000USD76,073,000USD64,768,000USD91,824,000USD86,087,000USD70,582,000USD
    Common Stock1,883,000USD1,521,000USD1,503,000USD1,191,000USD1,020,000USD913,000USD903,000USD782,000USD
    Capital Stock2,933,000USD1,521,000USD1,503,000USD1,191,000USD1,020,000USD913,000USD903,000USD782,000USD
    Retained Earnings-1,939,789,000USD-1,919,594,000USD-1,906,014,000USD-1,795,455,000USD-1,613,431,000USD-1,392,748,000USD-1,165,470,000USD-960,721,000USD
    Cash28,647,000USD25,802,000USD28,677,000USD15,364,000USD90,541,000USD105,138,000USD71,898,000USD31,836,000USD
    Cash And Short Term Investments46,631,000USD59,283,000USD80,409,000USD84,852,000USD157,580,000USD208,491,000USD390,972,000USD332,371,000USD
    Total Current Assets238,066,000USD209,014,000USD188,774,000USD205,435,000USD254,423,000USD314,196,000USD479,064,000USD447,248,000USD
    Total Current Liabilities96,098,000USD91,457,000USD79,685,000USD82,355,000USD71,058,000USD102,503,000USD96,705,000USD92,019,000USD
    Net Debt111,991,000USD151,961,000USD150,951,000USD142,113,000USD68,954,000USD-80,527,000USD-52,106,000USD-27,262,000USD
    Short Long Term Debt Total140,638,000USD177,763,000USD179,628,000USD157,477,000USD159,495,000USD24,611,000USD19,792,000USD4,574,000USD
    Long Term Debt140,638,000USD174,726,000USD173,753,000USD149,284,000USD149,082,000USD———
    Short Term Investments17,984,000USD33,481,000USD51,732,000USD69,488,000USD67,039,000USD103,353,000USD319,074,000USD300,535,000USD
    Net Receivables89,587,000USD78,881,000USD60,137,000USD52,049,000USD35,499,000USD41,850,000USD39,879,000USD64,652,000USD
    Inventory92,746,000USD53,160,000USD42,110,000USD54,573,000USD48,382,000USD41,905,000USD24,968,000USD39,032,000USD
    Accounts Payable8,994,000USD11,709,000USD3,799,000USD3,588,000USD3,873,000USD629,000USD3,068,000USD16,863,000USD
    Property Plant Equipment Net12,403,000USD17,650,000USD25,604,000USD29,805,000USD33,563,000USD39,014,000USD33,372,000USD14,677,000USD
    Property Plant Equipment Gross25,283,000USD35,497,000USD42,632,000USD29,805,000USD33,563,000USD39,014,000USD33,372,000USD14,677,000USD
    Accumulated Other Comprehensive Income4,000USD13,000USD13,000USD-19,000USD-6,000USD257,000USD85,000USD-87,000USD
    Common Stock Shares Outstanding166,707,000shares152,449,000shares138,135,000shares108,996,407shares98,471,000shares90,774,000shares81,779,000shares73,193,000shares
    Non Current Assets Total17,811,000USD24,133,000USD33,732,000USD45,516,000USD51,283,000USD39,360,000USD33,718,000USD14,931,000USD
    Non Current Liabilities Total145,446,000USD175,341,000USD176,794,000USD155,024,000USD157,078,000USD14,561,000USD12,242,000USD0USD
    Non Current Liabilities Other4,808,000USD615,000USD241,000USD241,000USD7,996,000USD14,561,000USD12,242,000USD—
    Non Currrent Assets Other5,408,000USD6,483,000USD8,128,000USD15,711,000USD17,720,000USD346,000USD346,000USD254,000USD
    Net Working Capital141,968,000USD117,557,000USD109,089,000USD123,080,000USD183,365,000USD211,693,000USD382,359,000USD355,229,000USD
    Unclassified Equity1,949,302,000USD1,882,888,000USD1,869,022,000USD1,806,664,000USD1,688,967,000USD1,627,157,000USD1,567,414,000USD1,329,404,000USD
    Short Term Debt—3,037,000USD3,075,000USD2,694,000USD2,417,000USD10,050,000USD7,550,000USD4,574,000USD
    Unclassified Non Current Liabilities——2,800,000USD5,258,000USD————
    Other Liab———241,000USD————
    Other Assets———15,711,000USD17,720,000USD16,623,000USD346,000USD254,000USD
    Net Tangible Assets———13,572,000USD77,570,000USD236,492,000USD403,835,000USD370,160,000USD
    Unclassified Non Current Assets———-15,711,000USD-17,720,000USD-16,623,000USD——
    Short Long Term Debt—————7,053,000USD5,624,000USD4,574,000USD
    Unclassified Current Liabilities—————-7,053,000USD-5,624,000USD-4,574,000USD
    Unclassified Current Assets———————-11,193,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-8,111,000USD-2,954,000USD-17,495,000USD-2,381,000USD2,635,000USD3,663,000USD-4,848,000USD-9,235,000USD
    Depreciation529,000USD537,000USD615,000USD611,000USD551,000USD581,000USD958,000USD641,000USD
    Stock Based Compensation2,976,000USD2,179,000USD2,852,000USD2,797,000USD2,511,000USD2,295,000USD2,722,000USD4,570,000USD
    Other Non Cash Items83,000USD120,000USD11,719,000USD96,000USD-104,000USD24,000USD247,000USD2,842,000USD
    Change To Account Receivables5,894,000USD-8,540,000USD-1,116,000USD-1,195,000USD145,000USD-11,842,000USD6,669,000USD-8,386,000USD
    Change To Inventory-169,000USD-14,187,000USD2,940,000USD-16,033,000USD-3,772,000USD-7,210,000USD-3,086,000USD-391,000USD
    Change In Working Capital2,983,000USD-9,066,000USD3,640,000USD-11,991,000USD-14,463,000USD-18,343,000USD4,292,000USD-3,422,000USD
    Total Cash From Operating Activities-1,540,000USD-9,184,000USD1,331,000USD-10,868,000USD-8,870,000USD-11,780,000USD3,371,000USD-4,604,000USD
    Capital Expenditures-391,000USD0USD0USD-208,000USD-109,000USD-638,000USD-431,000USD-637,000USD
    Free Cash Flow-1,931,000USD-9,184,000USD1,331,000USD-11,076,000USD-8,979,000USD-12,418,000USD2,940,000USD-5,241,000USD
    Investments-548,000USD-5,472,000USD11,858,000USD7,334,000USD2,273,000USD11,418,000USD3,970,000USD2,048,000USD
    Total Cashflows From Investing Activities-939,000USD-5,456,000USD11,858,000USD7,334,000USD2,273,000USD11,418,000USD3,970,000USD2,048,000USD
    Total Cash From Financing Activities-51,000USD219,000USD13,363,000USD781,000USD64,000USD423,000USD14,000USD492,000USD
    Sale Purchase Of Stock-51,000USD———————
    Change In Cash-2,530,000USD-14,421,000USD26,552,000USD-2,753,000USD-6,533,000USD61,000USD7,355,000USD-2,064,000USD
    Begin Period Cash Flow28,647,000USD43,068,000USD16,515,999USD19,269,000USD25,802,000USD25,741,000USD18,386,000USD20,450,000USD
    End Period Cash Flow26,117,000USD28,647,000USD43,068,000USD16,516,000USD19,269,000USD25,802,000USD25,741,000USD18,386,000USD
    Other Cashflows From Financing Activities-51,000USD219,000USD-14,286,000USD781,000USD64,000USD423,000USD14,000USD492,000USD
    Net Borrowings—-4,792,000USD———0USD——
    Issuance Of Capital Stock—-1,531,000USD——64,000USD0USD——
    Other Cashflows From Investing Activities—-37,000USD11,858,000USD—42,000USD27,000USD4,401,000USD—
    Unclassified Financing Cash Flow—6,323,000USD27,649,000USD—————
    Unclassified Investing Cash Flow——-11,858,000USD———-3,970,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-20,195,000USD-13,580,000USD-110,559,000USD-182,024,000USD-220,683,000USD-227,278,000USD-204,749,000USD-178,840,000USD
    Depreciation2,314,000USD2,492,000USD2,899,000USD2,889,000USD3,021,000USD2,847,000USD2,044,000USD1,513,000USD
    Stock Based Compensation10,339,000USD12,962,000USD32,854,000USD42,980,000USD46,851,000USD50,218,000USD51,411,000USD33,367,000USD
    Other Non Cash Items11,831,000USD3,200,000USD-773,000USD-251,000USD904,000USD1,429,000USD1,050,000USD890,000USD
    Change To Account Receivables-10,706,000USD-18,744,000USD-8,088,000USD-16,550,000USD6,351,000USD-1,971,000USD24,773,000USD-22,778,000USD
    Change To Inventory-31,052,000USD-11,050,000USD12,463,000USD-6,191,000USD-6,477,000USD-16,937,000USD14,064,000USD-29,122,000USD
    Change In Working Capital-31,880,000USD-27,603,000USD16,790,000USD-10,506,000USD-35,079,000USD-13,008,000USD29,233,000USD-45,424,000USD
    Total Cash From Operating Activities-27,591,000USD-22,529,000USD-58,789,000USD-146,912,000USD-203,354,000USD-184,820,000USD-124,580,000USD-191,805,000USD
    Capital Expenditures-317,000USD-1,706,000USD-1,545,000USD-1,825,000USD-3,022,000USD-6,813,000USD-7,154,000USD-9,171,000USD
    Free Cash Flow-27,908,000USD-24,235,000USD-60,334,000USD-148,737,000USD-206,376,000USD-191,633,000USD-131,734,000USD-200,976,000USD
    Investments16,228,000USD18,714,000USD28,852,000USD-3,324,000USD35,719,000USD215,768,000USD-14,629,000USD-269,404,000USD
    Total Cashflows From Investing Activities16,009,000USD18,714,000USD17,995,000USD-3,324,000USD32,729,000USD208,955,000USD-21,783,000USD-278,550,000USD
    Net Borrowings-12,755,000USD0USD24,350,000USD0USD148,963,000USD26,000USD26,000USD-25,000,000USD
    Total Cash From Financing Activities14,427,000USD940,000USD54,107,000USD75,059,000USD156,028,000USD9,105,000USD186,425,000USD357,608,000USD
    Issuance Of Capital Stock26,169,000USD0USD29,737,000USD75,145,000USD0USD0USD162,151,000USD363,128,000USD
    Change In Cash2,845,000USD-2,875,000USD13,313,000USD-75,177,000USD-14,597,000USD33,240,000USD40,062,000USD-112,747,000USD
    Begin Period Cash Flow25,802,000USD28,677,000USD15,364,000USD90,541,000USD105,138,000USD71,898,000USD31,836,000USD144,583,000USD
    End Period Cash Flow28,647,000USD25,802,000USD28,677,000USD15,364,000USD90,541,000USD105,138,000USD71,898,000USD31,836,000USD
    Other Cashflows From Investing Activities98,000USD27,000USD13,000USD-1,499,000USD35,751,000USD215,768,000USD25,000USD25,000USD
    Other Cashflows From Financing Activities-150,000,000USD940,000USD2,000USD-86,000USD7,065,000USD9,079,000USD24,274,000USD357,608,000USD
    Unclassified Financing Cash Flow151,013,000USD———-7,065,000USD-9,079,000USD-24,300,000USD-357,608,000USD
    Unclassified Investing Cash Flow—1,679,000USD-9,325,000USD3,324,000USD-35,719,000USD-215,768,000USD——
    Change To Liabilities———-578,000USD3,278,000USD4,605,000USD2,448,000USD13,958,000USD
    Sale Purchase Of Stock————7,065,000USD9,079,000USD186,425,000USD382,608,000USD
    Cash And Cash Equivalents Changes————-14,597,000USD33,240,000USD40,062,000USD-112,747,000USD
    Unclassified Operating Cash Flow——————-3,569,000USD-3,311,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductAponvie3,394,000USD0001193125-26-215755
    Q1 2026Quarterly · 2026-03-31ProductCINVANTI20,535,000USD0001193125-26-215755
    Q1 2026Quarterly · 2026-03-31ProductSUSTOL547,000USD0001193125-26-215755
    Q1 2026Quarterly · 2026-03-31ProductZYNRELEF10,235,000USD0001193125-26-215755
    Q4 2025Quarterly · 2025-12-31ProductAponvie3,813,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductCINVANTI22,918,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductSUSTOL1,329,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductZYNRELEF12,528,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductAponvie11,571,000USD0001193125-26-073515
    FY 2025Yearly · 2025-12-31ProductCINVANTI96,758,000USD0001193125-26-073515
    FY 2025Yearly · 2025-12-31ProductSUSTOL8,503,000USD0001193125-26-073515
    FY 2025Yearly · 2025-12-31ProductZYNRELEF38,072,000USD0001193125-26-073515
    Q3 2025Quarterly · 2025-09-30ProductAponvie3,034,000USD0001193125-25-263618
    Q3 2025Quarterly · 2025-09-30ProductCINVANTI23,955,000USD0001193125-25-263618
    Q3 2025Quarterly · 2025-09-30ProductSUSTOL1,911,000USD0001193125-25-263618
    Q3 2025Quarterly · 2025-09-30ProductZYNRELEF9,313,000USD0001193125-25-263618
    Q2 2025Quarterly · 2025-06-30ProductAponvie2,464,000USD0000950170-25-105475
    Q2 2025Quarterly · 2025-06-30ProductCINVANTI24,143,000USD0000950170-25-105475
    Q2 2025Quarterly · 2025-06-30ProductSUSTOL2,404,000USD0000950170-25-105475
    Q2 2025Quarterly · 2025-06-30ProductZYNRELEF8,189,000USD0000950170-25-105475
    Q1 2025Quarterly · 2025-03-31ProductAponvie2,260,000USD0001193125-26-215755
    Q1 2025Quarterly · 2025-03-31ProductCINVANTI25,742,000USD0001193125-26-215755
    Q1 2025Quarterly · 2025-03-31ProductSUSTOL2,859,000USD0001193125-26-215755
    Q1 2025Quarterly · 2025-03-31ProductZYNRELEF8,042,000USD0001193125-26-215755
    Q4 2024Quarterly · 2024-12-31ProductAponvie1,933,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductCINVANTI26,873,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductSUSTOL3,518,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductZYNRELEF8,457,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductAponvie4,518,000USD0001193125-26-073515
    FY 2024Yearly · 2024-12-31ProductCINVANTI100,079,000USD0001193125-26-073515
    FY 2024Yearly · 2024-12-31ProductSUSTOL14,142,000USD0001193125-26-073515
    FY 2024Yearly · 2024-12-31ProductZYNRELEF25,546,000USD0001193125-26-073515
    Q3 2024Quarterly · 2024-09-30ProductAponvie1,140,000USD0001193125-25-263618
    Q3 2024Quarterly · 2024-09-30ProductCINVANTI22,662,000USD0001193125-25-263618
    Q3 2024Quarterly · 2024-09-30ProductSUSTOL2,763,000USD0001193125-25-263618
    Q3 2024Quarterly · 2024-09-30ProductZYNRELEF6,245,000USD0001193125-25-263618
    Q2 2024Quarterly · 2024-06-30ProductAponvie1,020,000USD0000950170-25-105475
    Q2 2024Quarterly · 2024-06-30ProductCINVANTI24,927,000USD0000950170-25-105475
    Q2 2024Quarterly · 2024-06-30ProductSUSTOL4,246,000USD0000950170-25-105475
    Q2 2024Quarterly · 2024-06-30ProductZYNRELEF5,831,000USD0000950170-25-105475
    FY 2023Yearly · 2023-12-31ProductAponvie1,391,000USD0001193125-26-073515
    FY 2023Yearly · 2023-12-31ProductCINVANTI94,869,000USD0001193125-26-073515
    FY 2023Yearly · 2023-12-31ProductSUSTOL13,057,000USD0001193125-26-073515
    FY 2023Yearly · 2023-12-31ProductZYNRELEF17,727,000USD0001193125-26-073515
    FY 2022Yearly · 2022-12-31ProductCINVANTI87,245,000USD0000950170-25-028374
    FY 2022Yearly · 2022-12-31ProductSUSTOL10,231,000USD0000950170-25-028374
    FY 2022Yearly · 2022-12-31ProductZYNRELEF10,196,000USD0000950170-25-028374
    FY 2021Yearly · 2021-12-31ProductCINVANTI73,507,000USD0000950170-23-010603
    FY 2021Yearly · 2021-12-31ProductSUSTOL9,915,000USD0000950170-23-010603
    FY 2021Yearly · 2021-12-31ProductZYNRELEF2,924,000USD0000950170-23-010603
    FY 2020Yearly · 2020-12-31ProductCINVANTI87,815,000USD0001564590-22-007618
    FY 2020Yearly · 2020-12-31ProductSUSTOL823,000USD0001564590-22-007618
    FY 2019Yearly · 2019-12-31ProductCINVANTI132,162,000USD0001564590-22-007618
    FY 2019Yearly · 2019-12-31ProductSUSTOL13,806,000USD0001564590-22-007618
    FY 2018Yearly · 2018-12-31ProductCINVANTI56,200,000USD0001564590-20-007973
    FY 2018Yearly · 2018-12-31ProductSUSTOL21,300,000USD0001564590-20-007973

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.